Sean P. Nolan insider trades
Open-market stock purchases and sales by Sean P. Nolan, Director at Ventas, Inc, from SEC Form 4 filings since Mar 7, 2013.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -82%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 13, 2026 | VTR Ventas, Inc | Bought (not open market) | $185K |
| Jan 26, 2026 | TSHA Taysha Gene Therapies, Inc | Sold | $190K |
| Jan 23, 2026 | TSHA Taysha Gene Therapies, Inc | Sold | $650K |
| Jan 12, 2026 | TSHA Taysha Gene Therapies, Inc | Bought (not open market) | — |
| Jan 12, 2026 | TSHA Taysha Gene Therapies, Inc | Bought (not open market) | — |
Companies traded
- VTR Ventas, Inc: other filings, last May 13, 2026
- TSHA Taysha Gene Therapies, Inc: 2 buys, 2 sales, last Jan 26, 2026
- NLTX Neoleukin Therapeutics, Inc: other filings, last May 5, 2020
- AVXS AveXis, Inc: 6 sales, last May 15, 2018
- AQXP Aquinox Pharmaceuticals, Inc: other filings, last May 7, 2018
- ITMN Intermune Inc: 9 sales, last Sep 29, 2014